Hepatitis
B serologic testing involves measurement of several hepatitis B virus (HBV)-specific antigens and
antibodies. Different serologic “markers” or
combinations of markers are used to identify different phases of HBV infection and to determine whether a patient
has acute or chronic HBV infection,
is immune to HBV as a result of prior infection or vaccination, or is susceptible to infection.
Adapted
from: A Comprehensive
Immunization Strategy to EliminateTransmission
of Hepatitis B Virus Infection
in the United States: Recommendations
of the Advisory Committee on Immunization Practices.
Part
I: Immunization of Infants, Children, and Adolescents. MMWR 2005;54(No. RR-16).
No comments:
Post a Comment